Committed to improving the lives of people living
with serious medical conditions

Committed to improving the lives of people living with serious medical conditions

At Collegium Pharmaceutical, we are building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. We have a portfolio of meaningfully differentiated medications to treat serious medical conditions, including moderate-to-severe pain and acute migraine.

News and Press

Join the Collegium team

News and Press

  • Collegium Reports Second Quarter 2022 Financial Results

    Read More
  • Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022

    Read More
  • Collegium to Participate in H.C. Wainwright Global Investment Conference

    Read More
  • Collegium Reports First Quarter 2022 Financial Results

    Read More